Cargando…
Assessment of the oncological outcomes of three different bacillus Calmette–Guérin strains in patients with high-grade T1 non-muscle-invasive bladder cancer
OBJECTIVE: : To determine whether there are significant differences in oncological outcomes between three different bacillus Calmette–Guérin (BCG) strains used for adjuvant intravesical immunotherapy in patients with high-grade T1 (T1HG) non-muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHO...
Autores principales: | Nowak, Łukasz, Krajewski, Wojciech, Moschini, Marco, Chorbińska, Joanna, Poletajew, Sławomir, Tukiendorf, Andrzej, Muilwijk, Tim, Joniau, Steven, Tafuri, Alessandro, Antonelli, Alessandro, Orlando, Rossella, Di Trapani, Ettore, Alvarez-Maestro, Mario, Simone, Giuseppe, Zamboni, Stefania, Simeone, Claudio, Marconi, Maria Cristina, Mastroianni, Riccardo, Piszczek, Radosław, Xylinas, Evanguelos, Zdrojowy, Romuald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954505/ https://www.ncbi.nlm.nih.gov/pubmed/33763252 http://dx.doi.org/10.1080/2090598X.2021.1874628 |
Ejemplares similares
-
The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status
por: Nowak, Łukasz, et al.
Publicado: (2020) -
Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette–Guérin failure
por: Chiancone, Francesco, et al.
Publicado: (2021) -
Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors
por: Krajewski, Wojciech, et al.
Publicado: (2021) -
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes
por: Krajewski, Wojciech, et al.
Publicado: (2020) -
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
por: Krajewski, Wojciech, et al.
Publicado: (2020)